Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A policy approach to the development of molecular diagnostic tests.

Literature DB >> 21057480

A policy approach to the development of molecular diagnostic tests.

Abstract

Efficiently generating evidence of clinical utility is a major challenge for ensuring clinical adoption of valuable diagnostics. A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests.

Mesh：

Substances：
Biomarkers

Year: 2010 PMID： 21057480 DOI： 10.1038/nbt1110-1157

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

13 in total

1. Why Medicare has not established criteria for coverage decisions.

Authors: Sean R Tunis
Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245

2. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.

Authors: Sean R Tunis; Steven D Pearson
Journal: Health Aff (Millwood) Date: 2006 Sep-Oct Impact factor: 6.301

3. The prognostic role of a gene signature from tumorigenic breast-cancer cells.

Authors: Rui Liu; Xinhao Wang; Grace Y Chen; Piero Dalerba; Austin Gurney; Timothy Hoey; Gavin Sherlock; John Lewicki; Kerby Shedden; Michael F Clarke
Journal: N Engl J Med Date: 2007-01-18 Impact factor: 91.245

4. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Authors: Soonmyung Paik; Gong Tang; Steven Shak; Chungyeul Kim; Joffre Baker; Wanseop Kim; Maureen Cronin; Frederick L Baehner; Drew Watson; John Bryant; Joseph P Costantino; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Journal: J Clin Oncol Date: 2006-05-23 Impact factor: 44.544

5. Ethical and scientific implications of the globalization of clinical research.

Authors: Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman
Journal: N Engl J Med Date: 2009-02-19 Impact factor: 91.245

6. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

Authors: Anil Potti; Sayan Mukherjee; Rebecca Petersen; Holly K Dressman; Andrea Bild; Jason Koontz; Robert Kratzke; Mark A Watson; Michael Kelley; Geoffrey S Ginsburg; Mike West; David H Harpole; Joseph R Nevins
Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245

7. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

Authors: B Modan; P Hartge; G Hirsh-Yechezkel; A Chetrit; F Lubin; U Beller; G Ben-Baruch; A Fishman; J Menczer; J P Struewing; M A Tucker; S Wacholder
Journal: N Engl J Med Date: 2001-07-26 Impact factor: 91.245

8. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Authors: Andrea H Bild; Guang Yao; Jeffrey T Chang; Quanli Wang; Anil Potti; Dawn Chasse; Mary-Beth Joshi; David Harpole; Johnathan M Lancaster; Andrew Berchuck; John A Olson; Jeffrey R Marks; Holly K Dressman; Mike West; Joseph R Nevins
Journal: Nature Date: 2005-11-06 Impact factor: 49.962

9. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Authors: Chaitanya R Acharya; David S Hsu; Carey K Anders; Ariel Anguiano; Kelly H Salter; Kelli S Walters; Richard C Redman; Sascha A Tuchman; Cynthia A Moylan; Sayan Mukherjee; William T Barry; Holly K Dressman; Geoffrey S Ginsburg; Kelly P Marcom; Katherine S Garman; Gary H Lyman; Joseph R Nevins; Anil Potti
Journal: JAMA Date: 2008-04-02 Impact factor: 56.272